Merck & Co., Inc. (6MK.DE)

EUR 73.9

(-1.2%)

EBITDA Summary of Merck & Co., Inc.

  • Merck & Co., Inc.'s latest annual EBITDA in 2023 was 6.9 Billion USD , down -59.53% from previous year.
  • Merck & Co., Inc.'s latest quarterly EBITDA in 2024 Q2 was 7.53 Billion USD , up 7.06% from previous quarter.
  • Merck & Co., Inc. reported an annual EBITDA of 21.31 Billion USD in 2022, up 34.34% from previous year.
  • Merck & Co., Inc. reported an annual EBITDA of 13.86 Billion USD in 2021, up 52.96% from previous year.
  • Merck & Co., Inc. reported a quarterly EBITDA of 7.02 Billion USD for 2024 Q1, up 1629.01% from previous quarter.
  • Merck & Co., Inc. reported a quarterly EBITDA of -4.86 Billion USD for 2023 Q2, down -225.51% from previous quarter.

Annual EBITDA Chart of Merck & Co., Inc. (2023 - 1989)

Historical Annual EBITDA of Merck & Co., Inc. (2023 - 1989)

Year EBITDA EBITDA Growth
2023 6.9 Billion USD -59.53%
2022 21.31 Billion USD 34.34%
2021 13.86 Billion USD 52.96%
2020 10.18 Billion USD -29.65%
2019 12.87 Billion USD 25.65%
2018 13.99 Billion USD 24.0%
2017 11.95 Billion USD -8.33%
2016 10.82 Billion USD 13.15%
2015 12.44 Billion USD -58.51%
2014 19.2 Billion USD 130.17%
2013 13.33 Billion USD -22.7%
2012 16.43 Billion USD 10.32%
2011 15.45 Billion USD -14.21%
2010 11.4 Billion USD 327.46%
2009 -5.01 Billion USD -173.62%
2008 6.81 Billion USD -47.86%
2007 7.6 Billion USD 118.35%
2006 5.95 Billion USD -22.82%
2005 7.56 Billion USD 2.26%
2004 8.2 Billion USD -19.69%
2003 9.88 Billion USD -14.72%
2002 10.32 Billion USD 1.2%
2001 10.41 Billion USD 13.61%
2000 10.68 Billion USD 27.71%
1999 9.05 Billion USD 43.17%
1998 7.39 Billion USD -6.69%
1997 6.7 Billion USD 11.25%
1996 5.91 Billion USD 8.43%
1995 5.26 Billion USD -7.4%
1994 5.28 Billion USD 2.11%
1993 4.3 Billion USD 32.28%
1992 3.81 Billion USD 12.79%
1991 3.37 Billion USD 16.11%
1990 2.9 Billion USD 18.2%
1989 2.45 Billion USD 18.65%

Peer EBITDA Comparison of Merck & Co., Inc.

Name EBITDA EBITDA Difference
Bayer Aktiengesellschaft 4.2 Billion EUR -64.101%
Sanofi 11.99 Billion EUR 42.427%